We are pleased to announce that we have transitioned to a new pack size of 1 vial for Nelarabine Injection, 250 mg per 50 mL (5 mg/mL), NDC – 71288-165-54, in a single-dose vial, to replace the previous Nelarabine Injection, 250 mg per 50 mL (5 mg/mL), NDC – 71288-165-53 pack of 6 vials.
ABOUT NELARABINE INJECTION
Nelarabine Injection is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens.
For full prescribing and safety information, please click on the following link.
Learn more about Nelarabine Injection
